Elotuzumab

ELOTUZUMAB- elotuzumab injection, powder, lyophilized, for solution
Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company

Storage and Handling

REFRIGERATE AT 2°C TO 8°C (36°F TO 46°F). DO NOT FREEZE OR SHAKE. PROTECT FROM LIGHT.

Package/Label Display Panel

For Export
ELOTUZUMAB INJECTION, POWDER,
LYOPHILIZED, FOR SOLUTION
300MG/1VIAL BNU
LIST 1324383 SAP FIN# 1324383
LOT ??????? QTY 144
EXP. ??????? MFG. ???????

144 VIALS X 300 MILLIGRAM

CAUTION: FOR MANUFACTURING, PROCESSING, OR
REPACKING. UNITED STATES LAW PROHIBITS
DISPENSING WITHOUT PRESCRIPTION.

SEE ENCLOSED PACKAGE INSERT FOR USAGE
INFORMATION.

REFRIGERATE AT 2°C TO 8°C (36°F TO 46°F).
DO NOT FREEZE OR SHAKE.
PROTECT FROM LIGHT.


MFD. BY: BRISTOL-MYERS SQUIBB HOLDINGS PHARMA,
LTD. LIABILITY COMPANY
BO. TIERRAS NUEVAS, RT. 686, KM 2.3MANATI, PR 00674

300mg-elotu-bnulabel.jpg
(click image for full-size original)

Package/Label Display Panel

For Export
ELOTUZUMAB INJECTION, POWDER,
LYOPHILIZED, FOR SOLUTION
400MG/1VIAL BNU
LIST 1345536 SAP FIN# 1345536
LOT ??????? QTY 144
EXP. ??????? MFG. ???????

144 VIALS X 400 MILLIGRAM

CAUTION: FOR MANUFACTURING, PROCESSING, OR
REPACKING. UNITED STATES LAW PROHIBITS
DISPENSING WITHOUT PRESCRIPTION.

SEE ENCLOSED PACKAGE INSERT FOR USAGE
INFORMATION.

REFRIGERATE AT 2°C TO 8°C (36°F TO 46°F).
DO NOT FREEZE OR SHAKE.
PROTECT FROM LIGHT.


MFD. BY: BRISTOL-MYERS SQUIBB HOLDINGS PHARMA,
LTD. LIABILITY COMPANY
BO. TIERRAS NUEVAS, RT. 686, KM 2.3MANATI, PR 00674

400mg-elotu-bnulabel.jpg
(click image for full-size original)
ELOTUZUMAB elotuzumab injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NHRIC:0590-2291
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ELOTUZUMAB (ELOTUZUMAB) ELOTUZUMAB 300 mg
Inactive Ingredients
Ingredient Name Strength
CITRIC ACID MONOHYDRATE
POLYSORBATE 80
SODIUM CITRATE, UNSPECIFIED FORM
SUCROSE
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:0590-2291-09 144 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only 11/30/2015
ELOTUZUMAB elotuzumab injection, powder, lyophilized, for solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NHRIC:0590-4522
Route of Administration INTRAVENOUS DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
ELOTUZUMAB (ELOTUZUMAB) ELOTUZUMAB 300 mg
Inactive Ingredients
Ingredient Name Strength
CITRIC ACID MONOHYDRATE
POLYSORBATE 80
SODIUM CITRATE, UNSPECIFIED FORM
SUCROSE
Packaging
# Item Code Package Description Multilevel Packaging
1 NHRIC:0590-4522-09 144 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 CARTON None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
Export only 11/30/2015
Labeler — Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company (090413568)

Revised: 03/2016 Bristol-Myers Squibb Holdings Pharma, Ltd. Liability Company

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2020. All Rights Reserved.